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Abstract
The presence of amyloid-b (Ab) deposits in selected brain regions is a hallmark of Alzheimer’s disease (AD). The
amyloid deposits have “chaperone molecules” which play critical roles in amyloid formation and toxicity. We report
here that treatment of rat hippocampal neurons with Ab-acetylcholinesterase (Ab-AChE) complexes induced neur-
ite network dystrophia and apoptosis. Moreover, the Ab-AChE complexes induced a sustained increase in intracel-
lular Ca
2+ as well as a loss of mitochondrial membrane potential. The Ab-AChE oligomers complex also induced
higher alteration of Ca
2+ homeostasis compared with Ab-AChE fibrillar complexes. These alterations in calcium
homeostasis were reversed when the neurons were treated previously with lithium, a GSK-3b inhibitor; Wnt-7a
ligand, an activator for Wnt Pathway; and an N-methyl-D-aspartate (NMDA) receptor antagonist (MK-801), demon-
strating protective roles for activation of the Wnt signaling pathway as well as for NMDA-receptor inhibition. Our
results indicate that the Ab-AChE complexes enhance Ab-dependent deregulation of intracellular Ca
2+ as well as
mitochondrial dysfunction in hippocampal neurons, triggering an enhanced damage than Ab alone. From a thera-
peutic point of view, activation of the Wnt signaling pathway, as well as NMDAR inhibition may be important fac-
tors to protect neurons under Ab-AChE attack.
Background
Alzheimer’s disease (AD) is an age-related neurodegen-
erative disease characterized by selective neuronal cell
death that affects brain areas related to memory and
learning [1]. The neuropathological hallmarks of AD
patients are the presence of senile plaques and neurofi-
brillary tangles in the brain [2]. Senile plaques are aggre-
gates of deposited amyloid-b peptide (Ab), surrounded
by dystrophic neurites and reactive glial cells [2]. Ab-
peptide is the main constituent of senile plaques and a
major neurotoxic agent [2]. Other proteins associated to
amyloid deposits, known as “chaperone molecules” [3]
include laminin, apolipoprotein E and
acetylcholinesterase (AChE) [3-5]. In fact, AChE has
been found to co-localize with Ab deposits such at
those present in pre-amyloid diffuse deposits, mature
senile plaques and cerebral blood vessels [6,7]. Most of
the cortical AChE activity present in AD brain is predo-
minantly associated to the amyloid core of senile pla-
ques rather than with the neuritic component found in
the periphery [7]. More than 10 years ago, we found
that AChE a key enzyme in the degradation of the neu-
rotransmitter acetylcholine, present in cholinergic term-
inals accelerates Ab aggregation [4], promoting the
formation of a stable complex with the enzyme (Ab-
AChE complex) [8]. We showed for the first time that a
macromolecule found in the synapse interacts with Ab
to form a complex which alters the normal synaptic
function in hippocampal neurons. In vivo studies
showed that AChE infused stereotaxically into the CA1
region of the rat hippocampus promotes novel plaque-
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dies support our initial observation indicating that
AChE accelerates Ab deposition, in fact a double trans-
genic mouse over expressing both the human APP con-
taining the Swedish mutation and the human AChE has
been developed. Such double transgenic mice start to
form amyloid plaques around 3 months, earlier than
mice expressing only the APP transgene. Moreover, the
double AChE-APP transgenic mouse presents more and
larger plaques than the control animals, as well as some
behavioural deterioration, as demonstrated by a working
memory test [11]. Indeed, injection of the complex into
the rat hippocampus produces neuronal cell loss and
astrocyte hypertrophy [10].
The early events triggered in neurons in response to
Ab peptide have been largely studied [12-16]. It has
been described that Ab oligomers/fibrils induce intracel-
lular calcium deregulation that leads to apoptosis
through mitochondria dysfunction, whether by direct
interaction with isolated mi t o c h o n d r i ao rb yi n d i r e c t
association with the neuronal membrane [12-16]. We
report here the early effects that Ab-AChE complexes
induce in rat hippocampal neurons using live-cell ima-
ging techniques. Results show that Ab-AChE complexes
a r em o r et o x i ct h a nt h eA b fibrils alone on rat hippo-
campal neurons. In fact, neurons treated with Ab-AChE
complexes showed a much disrupted neurite network
compared to neurons treated with Ab. One the earliest
effect of Ab-AChE complexes is an increase in intracel-
lular calcium, which leads to the loss of the mitochon-
drial membrane potential, this being in agreement with
the notion that calcium homeostasis and mitochondrial
function are the main targets of these complexes.
Results
Ab-AChE complexes disrupt neuronal morphology and
induce intracellular calcium increase in hippocampal
neurons
In order to evaluate the morphological changes induced
by Ab-AChE complexes in hippocampal neurons, the
following immunofluorescence studies were performed.
Hippocampal neurons were treated with 5 μMo fA b
preparations: Ab fibrils (Abf), Ab oligomers (Abo), Ab-
AChE mostly fibers (Ab-AChEf) and Ab-AChE mostly
oligomers (Ab-AChEo) (see additional file 1). We used
an Ab reverse sequence (5 μM) and AChE (5 nM), for 1
hr as controls. Neurons were stained for MAP-1B (Fig.
1A) or NF-200 (Table 1). Neurons treated with Abo
(Fig. 1Ac) were observed to have a higher loss of their
neurite network compared to neurons treated with Abf
(fig 1Ae). Furthermore, while neurons treated with Ab-
AChEo (Fig. 1Ab) appeared to have a small, loss of their
neuritic network, neurons treated with Ab-AChEf (Fig.
1Ad) were observed to have more damage on their
neurite network than neurons treated with Abf( F i g .
1Ae). Complementary immunofluorescence studies with
a NF-200 antibody showed that Ab-AChEf significantly
decreased the length of the neurites by 40%, in compari-
son with Abf-treated neurons (see Table 1). Addition-
ally, we evaluated the effect of different Ab and Ab-
AChE preparations on synaptic proteins (Additional file
2). We performed an immunofluorescence assay for pre-
synaptic protein synapsin-1 and postsynaptic protein
PSD-95. In agreement with previous studies, Abo treat-
ment decreased the immunostaining for PSD-95
whereas Abf had no effect [17]. Also, Ab-AChEo treat-
ment induced a critical decrease in PSD-95 immuno-
fluorescence similar to Abo preparations, whereas Ab-
AChEf had no effect (Additional file 2), suggesting that
Ab oligomers formed in the presence of AChE have a
similar synaptotoxicity to those formed in its absence.
To determine whether Ab-AChE is more toxic than Ab,
we performed cell viability studies using MTT, as an
indicator of cell viability. Abf alone decreased cell viabi-
lity by 35 ± 7% when compared with control, while Ab-
AChEf under the same conditions and concentration
reduced viability by 50 ± 6%, suggesting that the com-
plexes are significantly more toxic than Ab aggregates
alone at equal concentrations (Fig. 1B).
An increase in intracellular calcium has been observed
in Ab treated neurons as well as during glutamate exci-
totoxicity [18]. Therefore, we characterized calcium
homeostasis after exposure of hippocampal neurons to
Ab-AChEf. Neurons were loaded for 30 min with Fluo-3
AM and then cytosolic calcium levels were evaluated in
cells exposed to 5 nM AChE (Fig. 1C, silver circles), 5
μMA bf( F i g .1 C ,o p e nc i r c l e s )a n d5μMA b-AChEf
(Fig. 1C, closed circles). Neurons treated with Abfa n d
Ab-AChEf showed a marked and consistent calcium
increase, while treatment with AChE enzyme alone
showed no effect on the mobilization of intracellular cal-
cium. However, the final fluorescence levels reached
after 1 h treatment with Ab-AChEf were significantly
higher than Abf, indicating that Ab-AChEf complexes
induces a sustained higher increase in intracellular cal-
c i u m ,i nc o m p a r i s o nw i t hA b-treated neurons (Fig. 1C,
inset). Then, we evaluated whether the calcium increase
Table 1 Ab-AChE complex induces a neurite network loss
in hippocampal neurons
Treatment Neurite length (μm)
Control 65 ± 7
Ab (5 μM) 30 ± 4*
Ab-AChE (5 μM) 28 ± 5*
Determinations are representative of 3 different experiments carried out. Anti-
NF-200 antibody was used for the immunofluorescence analysis. Asterisk
indicated statistical difference between Control and Ab (*) p < 0.001, and
Control and Ab-AChE (*) p < 0.001.
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Page 2 of 15Figure 1 Ab and Ab-AChE complexes induce morphological changes, apoptosis and intracellular Ca
2+ increase in rat hippocampal
neurons. (A) Immunofluorescence for MAP-2 protein of 14 DIV hippocampal neurons treated with: (a) control, (b) 5 μMA b-AChEo, (c) 5 μM
Abo, (d) 5 μMA b-AChEf, (e) 5 μMA bf, (f) 5 nM AChE and (g) 5 μMA b42-1 for 1 h. Scale bar, 10 μm. (B) Cell viability was performed with the MTT
reduction assay in hippocampal neurons treated for 12 h with the indicated μM concentrations. *p ≤ 0.01 and **p ≤ 0.001 compared with the
control condition. (C) Hippoccampal neurons in culture were loaded with Fluo-3 AM (5 μM for 30 min at 37°C) to measure changes in free
intracellular Ca
2+. The graph shows normalized fluorescence intensities according to the ratio ΔF/Fo (arbitrary units) in function of time. Black bar
indicates onset of treatment. 5 μMA bf (White circle); 5 μMA b-AChEf (Black circle); 5 nM AChE (Grey circle). Inset shows the final normalized
fluorescence intensities reached at the end of 1 h of recording. *p ≤ 0.001 compared to control; #p ≤ 0.001 compared to the Ab-AChEf
treatment. (D) Detection of Caspase-3 activity in hippocampal neurons. The graph shows the activity of Caspase-3 under effect of different
preparation of Ab and Ab-AChE peptide. The cells were treated by 1 h at 37°C. Results are the mean ± S.E.M; *p < 0.05.
Dinamarca et al. Molecular Neurodegeneration 2010, 5:4
http://www.molecularneurodegeneration.com/content/5/1/4
Page 3 of 15observed by treatments trigger the apoptotic cascade
after 1 h treatment. The caspase-3 activity measure-
ments showed that Ab-AChEf significant increase the
caspase-3 activity compared with Abfo rA bo. On the
other hand, AChE treatment did not show any effect
(Fig. 1D). These results indicate that Ab-AChE com-
plexes showed a greater modification of intracellular cal-
cium homeostasis than Ab alone triggering the
activation of the apoptotic pathway.
Ab-AChE complexes induce neurotoxicity by alteration of
intracellular calcium
Given the effect of the Ab-AChE on intracellular cal-
cium homeostasis, we examined whether the Ab-AChEf
alter the integrity of the plasma membrane. We treated
hippocampal neurons with 5 μMA b-AChEf and then
loaded with calcein-AM and Fura-red. After 1 h treat-
ment the fluorescence of Fura-red in neurons treated
with Ab-AChEf (Fig. 2Ad) decreased respect to the con-
trol (Fig. 2Ac), whereas the calcein fluorescence was not
affected respect to the control (Fig. 2Aa and 2b), sug-
gesting that the Ab-AChEf treatment did not alters the
integrity of the plasma membrane. We also evaluated
whether Ab-AChEo preparation interacts with the neu-
ronal membrane through surface biotinyl assay. Fig. 2B
shows that Ab-AChEo interacts with the cell membrane,
suggesting that the effects observed are because the
complex is acting at the neuronal membrane level.
Then, we evaluated the effect of different concentrations
of Ab-AChEf and the source of calcium responsible for
the intracellular calcium increase. We determined the
behaviour of calcium levels in neurons loaded with
Fluo-3 AM and then treated with increasing Ab-AChEf
concentrations. We observed that the increase in the
cytoplasmic calcium levels correlated with increasing
Ab-AChEf concentrations (Fig. 2C). In order to deter-
mine the source of the intracellular calcium increase
induced by the complex, we treated neurons with the
complex (5 μMA b-AChEf) in the presence of the extra-
cellular calcium chelator, EGTA (2 mM), or the intracel-
lular calcium chelator, BAPTA-AM (30 μM). We
observed that treatment with EGTA prevented the
increase of intracellular calcium induced by the complex
(Fig. 2D). Additionally in neurons pre-incubated with
BAPTA-AM and treated with the complex, we observed
a ~ 2.8-fold increase in the intracellular calcium (Fig.
2D). These results suggest that intracellular calcium
deregulation induced by the complex is dependent on
extracellular calcium and that massive entrance of the
ion could release intracellular calcium reservoirs. In
order to study the role of the intracellular calcium
deregulation in the neurotoxic properties of Ab-AChE,
we performed MTT cell viability assays in the presence
of 2 mM EGTA, as indicated in Fig. 2E. Five μMA b-
AChEf induced ~ 55% cell death, while EGTA partially
reduced neuronal death triggered by the Ab-AChEf
complex (~ 25% reduction of viability), suggesting that
extracellular calcium has an important role, but is not
the only player in the mechanism of toxicity induced by
the complex.
Ab-AChE complexes induce mitochondrial membrane
potential loss in hippocampal neurons
To determine whether the cytosolic calcium dysregula-
tion induced by Ab-AChE complexes alter mitochon-
drial function; we analyzed the variations in
mitochondrial membrane potential (ΔΨmit)o fh i p p o -
campal neurons treated with the Ab-AChEf complex,
AChE and Abf, respectively (Fig. 3). In vivo confocal
images of hippocampal neurons exposed to Ab-AChEf
showed a severe loss of mitochondrial membrane
potential using TMRM
+, a mitochondrial potential
indicator which detects alterations in mitochondrial
membrane polarity (Fig. 3A) [19,20]. Photographs
registered at 30 min showed a large decrease in the
fluorescence of the mitochondrial potential indicator
after addition of 5 μMA b-AChEf when compared to
the beginning of the experiment (Fig. 3Aa, b). Quanti-
fication of the reduction in the mitochondria mem-
brane potential shows a decrease of -1 normalized
fluorescence unit when compared to start levels (Fig.
3A, c). Treatment with Abf( 5μM) alone induced par-
tial disturbances in ΔΨmit levels represented by a
decrease of ~ -0.4 normalized fluorescence units (Fig.
3B, a) and AChE treatment (5 nM) exhibited no altera-
tion of ΔΨmit levels (Fig. 3B, b). Fig. 3C shows the
quantification of mitochondrial potential levels reached
at the end of the experiment (1 h) in each condition.
Analysis of three independent experiments showed
that Ab-AChEf induced a significant decrease in ΔΨmit
that was 2-fold higher than the decrease induced by
Abf treatment, while AChE had no effect on ΔΨmit
(Fig. 3C). To evaluate the reversibility of the effect pro-
duced by Ab-AChEf treatment on calcium homeostasis
and ΔΨmit levels, hippocampal neurons were loaded
with Fluo-3 AM and TMRM
+, followed by the addition
of 5 μMA b-AChEf for 15 min, and then washed with
fresh KRH-glucose buffer. In these studies, the Ab-
AChEf induced calcium increase was completely
reversed to basal levels (Fig. 3D, closed circles), how-
ever, mitochondrial membrane potential loss was not
recovered after washing out of Ab-AChEf (Fig. 3D,
open circles). These results suggest that Ab-AChE
complexes could be acting at the neuronal surface,
triggering an entrance of calcium depending on the
presence of the complex; however, this intracellular
calcium deregulation produces an irreversible effect on
the mitochondrial membrane potential that could be
responsible for the higher toxicity levels presented by
Ab-AChE.
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Page 4 of 15Figure 2 Role of the intracellularcalcium increase in the toxicity of Ab-AChE complexes. (A) Hippocampal neurons were loaded with
Calcein-AM to analyze the neuronal integrity and with FuraRed as an indicator of intracellular free calcium. The confocal photographs
correspond to neurons before treatment (a, c and e) and after 1 h treatment with 5 μMA b-AChEf (b, d and f). (B) The figure shows a
representative SDS-PAGE of AChE immunoblot to detect Ab-AChEo complexes on neuronal surface by biotinylation. The graph shows a
quantification of two independent experiments, results are the mean ± S.E.M. (C) Hippocampal neurons were loaded with Fluo-3 AM and treated
with increasing Ab-AChEf concentrations (μM), indicated by the black bars on top of the graph. The complexes were not washed out in
between increasing concentrations. Fluorescence changes were recorded at 1 min intervals and are shown as ratio ΔF/Fo. (D) Final normalized
fluorescence intensities reached at the end of experiments are expressed over the control situation for the following treatments: 5 μMA b-AChEf;
2 mM EGTA; 30 μM BAPTA-AM; * p ≤ 0.001. (E) Cell viability was evaluated by MTT assay. Hippocampal neurons were treated for 24 h as follow:
5 μMA b-AChEf; 2 mM EGTA. Mean MTT reduction value was expressed as % of control situation; *p ≤ 0.001 compared with the control
condition; #p ≤ 0.005 compared to the Ab-AChEf treatment.
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induced by Ab-AChE complexes in hippocampal neurons
Treatment with Ab-AChE complexes caused a calcium
influx in hippocampal neurons and a severe reduction
in mitochondrial membrane potential. In order to study
t h er o l eo fm i t o c h o n d r i ai nt h ec a l c i u md e r e g u l a t i o n
induced by Ab-AChE, we treated hippocampal neurons
with Ab and Ab-AChE for 1 h and stained with Mito-
Tracker. In control neurons without treatment we
observed that most of the active mitochondria were
localized through neurites (Fig. 4Aa). In the case of
neurons treated with Ab-AChEf, the fluorescence of
active mitochondria decreased proportional to increasing
Ab-AChEf concentrations (Fig. 4Ab, c). Abf (Fig. 4Ad, e)
reduced the fluorescence of active mitochondria more
than Abo (Fig. 4Af, g), however both showed lower
effect than Ab-AChEf (Fig. 4B). AChE treatment had no
effect (Fig. 4Ah). The quantification of MitoTracker
fluorescence intensity indicated that Abf and Abo signif-
icant decreased the mitochondrial potential respect to
control neurons. However, Ab-AChEf treatment pro-
duced around 50% decrease in the mitochondrial
Figure 3 Mitochondrial potential loss produced by Ab-AChE complexes. Hippocampal neurons were loaded with TMRM
+ to measure
changes in ΔΨmit. Fluorescence changes were recorded at 1 min intervals and are shown as ratio ΔF/Fo. (A) Representative photographs of
neurons a time 0 (a) or after 30 min (b) of treatment with 5 μMA b-AChEf, in (c), the temporal quantification of the mitochondrial potential as
indicated by the black bar on top of the graph. (B) Neurons treated with 5 μMA bf (a) or 5 nM AChE (b). (C) Normalized fluorescence intensities
at the end of each treatment are expressed over the control as follow: 5 μMA b;5μMA b-AChEf; 5 nM AChE; * and # p ≤ 0.001. (D) Neurons
were loaded with Fluo-3 AM (black circle, 5 μM) and TMRM
+ (white circle, 30 nM) to measure changes in the mitochondrial membrane potential
(ΔΨmit). After a 5 min control period, 5 μMA b-AChEf was added (indicated by the black bar on top of the graph) followed by a wash with fresh
recording media.
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uptake [20,21]. Hippocampal neurons were loaded with
Rhod-2 and then treated with Abfa n dA b-AChEf. Abf
treatment produced an increase in the calcium uptake
whereas Ab-AChEf induced an acute mitochondrial cal-
cium increase, with a subsequent decrease in mitochon-
drial calcium levels (Fig. 4C). Interestingly, decrease in
mitochondrial calcium uptake correlates with severe
mitochondrial potential loss induced by Ab-AChE com-
plexes in neurons. These results suggest that Ab-AChEf
produces the release of mitochondrial calcium, accord-
ing with our previous result with the intracellular cal-
cium chelator BAPTA-AM (Fig. 2D).
Wnt-7a, lithium chloride and a glutamate receptor
antagonist, prevent the Ab-AChE induced neuronal
calcium deregulation in hippocampal neurons
Previous studies in our laboratory showed that lithium
and Wnt ligands protect neurons from Ab toxicity by
activation of the Wnt signaling pathway [22]. This path-
way is also implicated in the development of the nervous
system, and recently it has been demonstrated to regulate
synaptic differentiation and neurotransmission [23,24].
We performed calcium experiments using Fluo-3 AM in
neurons treated with Ab-AChEf alone (Fig. 5Aa) or co-
incubated with lithium or neurons pre-treated with Wnt-
7a ligand conditioned-medium for 24 h and then
exposed to Ab-AChEf (Fig. 5Ab). Lithium (10 mM) pre-
vented the intracellular calcium influx induced by the
complex (Fig. 5Ab, open squares). In addition, Wnt-7a
ligand also prevented the cytoplasmic calcium increase
induced by the complex in hippocampal neurons (Fig.
5Ab, open circles). The quantification of the changes in
fluorescence levels at 30 min into the experiment showed
a significant prevention in the calcium increase triggered
by Ab-AChEf by the presence of lithium (Fig. 5Ac) and
Wnt-7a ligand (Fig. 5Ad). Additionally, we tested the role
of the NMDA receptor in the intracellular calcium dereg-
ulation induced by the Ab-AChE complexes. In these
studies, we incubated hippocampal neurons with 5 μM
Ab-AChEf in the presence of NMDA receptor antagonist
MK-801 and cytoplasmic calcium changes were moni-
tored (Fig. 5B). The inhibition of NMDA receptor activity
blocked cytoplasmic calcium influx produced by the
complex, (Fig. 5Ba) and the quantitative analysis of three
independent experiments at 30 min into the experiments,
corroborating the complete inhibition of calcium influx
induced by Ab-AChEf in hippocampal neurons (Fig.
5Bb). Additionally, inhibition of NMDA receptors pre-
vented cytosolic calcium increase induced by 5 μMA b
treatment (data not shown). These results suggest that
both the activation of Wnt pathway and the inhibition of
NMDA receptor prevent the cytoplasmic calcium dereg-
ulation induced by Ab-AChE complexes in hippocampal
neurons.
Presence of AChE increases Ab oligomer formation and
neurotoxicity in hippocampal neurons
It has been suggested that Ab oligomers are responsible
for the toxic effects of Ab [25-27]. Additionally, Ab oli-
gomers induced an accelerated calcium influx, mito-
chondrial depolarization, decreased ATP levels, and
cytochrome c release in cortical neurons [28]. Therefore,
we decided to evaluate whether Ab-AChE containing Ab
oligomers, show the same toxicity found in hippocampal
neurons exposed to the complex containing Ab fibrils.
Ab was aggregated, at 37°C, in the absence or presence
of AChE enzyme and aliquots were taken at different
times of Ab aggregation and analyzed by electron
microscopy. The formation of Ab oligomers was faster
in the presence of enzyme AChE (compare picture Fig.
6Ac with 6Ad). The microphotographs show oligomeric
structures present at 1 h of AChE and Ab incubation
(Fig. 6Ad also, Additional file 1), where in the case of
Ab alone, oligomeric structures appear only after 2 h
incubation (Fig. 6Ae). Clearly, there are more Ab oligo-
mers formed in the presence of AChE, which corre-
spond to either protofibrils (Fig. 6Af arrow), or
amylospheroid assemblies (Fig. 6Ah, arrow head). Pre-
vious studies indicated that high Ab oligomer neurotoxi-
city is associated with an accelerated calcium influx and
mitochondrial impairment [28]. In addition, Ab oligo-
mers prepared in the presence of AChE were subjected
to non-denaturing electrophoresis gels and western blot-
ting for Ab (Fig. 6Ba). The western blot showed 3 bands
corresponding to monomers, dimmers and trimmers of
Ab when aggregation was performed without the pre-
sence of AChE enzyme (Fig. 6Ba, line 1). When Ab was
incubated with AChE, we observed the 3 bands for
monomers, dimmers and trimmers plus a high molecu-
lar weight band of 74 KDa (Fig. 6Ba, line 2). In order to
see whether AChE-Abo affect intracellular Ca
2+,h i p p o -
campal neurons were loaded with Fluo-3 AM. The use
of an oligomeric-rich preparation (Ab-AChEo) induced
a faster and prominent calcium increase (~ 0.6 normal-
ized fluorescence units during the first 10 min of treat-
ment) respect to neurons treated with normal Ab-
AChEf complexes (~ 0.2 normalized fluorescence units
during the first 10 min of treatment), indicating that the
oligomeric-rich preparation had a fast effect on calcium
homeostasis (Fig. 6Bb). These results are in agreement
with the evidence that indicates that Ab oligomers
induce a similar effect on cell viability and calcium
homeostasis in a human neuroblastoma cell line [28].
Discussion
AChE is an enzyme involved in diverse functions in
both central and peripheral nervous systems and it has
been demonstrated to be associated with senile plaques
[3]. On the other hand, a renewed interest in calcium as
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observation of polymorphism in a CALHM1 gene that
may influence calcium mutations and increase the risk
of AD [29]. Indeed, several studies indicate that familial
AD mutations in presenilins affect calcium homeostasis,
releasing intracellular calcium from ryanodine or IP3
channels [30].
We had reported here that Ab-AChE complex trigger
more neurodegeneration than the Ab alone, acting as a
chaperone protein which increases the toxicity of Ab pep-
tide, confirming previous studies both in vitro and in vivo
[9,10]. We have shown that a short exposure of hippocam-
pal neurons to Ab-AChE complexes caused an influx of
calcium with higher levels than the amyloid fibrils alone
and this increase was reversible and concentration-depen-
dent; in addition the calcium source for such increase was
the extracellular calcium present in the media, which
probably release some intracellular calcium reservoirs, as
mitochondria. Our results suggest that Ab-AChE com-
plexes are exerting their actions at the plasma membrane
level, possibly acting on a calcium channel or on some yet
unidentified cell surface receptor-channel that could
Figure 4 Role of mitochondria in the calcium increase induced by Ab-AChE. (A) Hippocampal neurons were treated with (a) control
medium, (b) 2 μMA b-AChEf, (c) 5 μMA b-AChEf, (d) 2 μMA bf, (e) 5 μMA bf, (f) 2 μMA bo, (g) 5 μMA bo and (h) 5 nM AChE for 1 h and stained
with MitoTracker (red stain in the insets) and Phalloidin (blue stain in the inset) to observe neuronal morphology. Bar = 10 μm. (B) Quantification
of MitoTracker fluorescence intensity representative of mitochondrial membrane potential of the different treatments. Results are the mean ± S.E.
M, in duplicate experiments, n = 2 independent experiments; *p < 0.05 (C) Hippocampal neurons were loaded with 5 μM Rhod-2 AM for 40 min
and mitochondrial calcium uptake were determined. Mitotracker Green™ (MTG) was used to estimate Rhod-2 signal in the mitochondria.
Treatment with 3 μMA bf gradually increased mitochondrial calcium uptake. Control experiments with reverse peptide Ab42-1 did not show
significant changes in mitochondrial calcium levels. However, 3 μMA b-AChEf complexes induced a rapid and acute mitochondrial calcium
increase, with a subsequent decrease in mitochondrial calcium levels.
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Page 8 of 15Figure 5 Lithium chloride, MK-801, and Wnt-7a prevent the calcium increase induced by the Ab-AChE complexes. Hippocampal neurons
were loaded with Fluo-3 AM and set for imaging in vivo experiments. Fluorescence changes were recorded at 1 min intervals and presented as
the ratio ΔF/Fo. (A) Neurons were treated with 5 μMA b-AChEf alone (black circle) (a), or co-incubated with 10 mM LiCl (white square), or
neurons were pre-incubated with Wnt-7a for 24 h before AChE-Ab treatment (white circle) (b). Final normalized fluorescence intensities reached
at the end of 1 h experiments are presented and expressed over the control situation using the following treatments: 5 μMA b-AChEf; 5 μMA b-
AChEf with 10 mM LiCl (c); Wnt-7a pre-incubation for 24 h before beginning the in vivo experiments (d); *p = 0.001 compared to control; #p =
0.001 compared to Ab-AChEf treatment. (B) Hippocampal neurons were treated with 5 μMA b-AChEf in the presence of 2 μM MK-801 during 1 h
(a), and cytoplasmic calcium levels were detected by confocal microscopy. Quantification of three independent experiments after 1 h incubation
(b); *p = 0.001 compared to Ab-AChEf treatment.
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Page 9 of 15activate calcium entry upon Ab complex interaction [14].
Disruption of intracellular homeostasis of Ca
2+ and K
+ by
opening of these channels, has been extensively proposed
as a mechanism of Ab neurotoxicity [14,18]. It has been
reported that Ab-induced activation of AChE in P19 cells
was mediated through the opening of L-type calcium
channels [31]. Also, it has been found that Ab induces
production of an amphiphilic monomeric isoform of
AChE through a mechanism that involves at L-type
calcium channels. This specif i ci n c r e a s ei nam i n o ri s o -
form of the enzyme has also been seen to be increasing in
transgenic mice that overexpress AbPP [32], as well as in
the brains of rats that received intracerebral injections of
Ab peptides [33]. It is also increased in the brain and cere-
brospinal fluid of patients with AD [34]. These studies
suggest an active role of the Ab-AChE complexes in the
AD pathology. Ab-AChE complexes and Ab treatment
had different effects over the mitochondrial membrane
Figure 6 Effect of Ab-AChE oligomers in hippocampal neurons. (A) Ab (5 μM) in the absence (a, c, e, g) and presence of 50 nM AChE (b, d,
f, h) was aggregated at 37°C without stirring. 5 μl aliquot was obtained at 0 (a, b); 1 (c, d); 2 (e, f) and 4 hr (g, h), stained with 2% uranyl acetate
and photographed with an electron microscope. More Ab oligomers were formed in the presence of AChE, corresponding to protofibrils (arrow)
(f), or amylospheroids (head-arrow) (h). Scale bar, 100 nm. (B) Western blot for 50 μMA b aggregated alone or in the presence of 50 nM AChE,
an aliquot of supernatant obtained after centrifugation was used (a). Hipoccampal neurons in culture were loaded with Fluo-3 AM (5 μM for 20
min at 37°C) to measure changes in free intracellular Ca
2+ every 1 min. The graphic shows normalized fluorescence intensities according to the
ratio ΔF/Fo (arbitrary units) in function of time. Black bar indicates onset of treatment. 5 μMA b-AChEf (black circle); 5 μMA b-AChEo (white circle)
(b).
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+ dye. Our
experiments indicated that Ab-AChE complexes affected
ΔΨmit more than Ab; also, we observed that the mitochon-
drial membrane potential was compromised in a non-
reversible manner, even when the calcium increase was
reverted after wash out. These events could be related
with previously described mitochondrial dysfunction
effects, which included the mitochondria Permeability
Transition Pore (mPTP) opening [35]. This structure is
involved in cytochrome c release, apoptotic mechanisms
on high levels of cytosolic calcium and oxidative stress
excess contribute to this structure opening and finally
affect mitochondrial membrane potential, ATP levels, and
mitochondrial calcium uptake as we observed in Fig. 4C
[35-37]. Our results indicate that the increased neurotoxi-
city of Ab-AChE complexes with regard to Ab aggregates
is probably related to a more rapid and non-reversible
increase of mitochondrial dysfunction or to some direct
effects at the mitochondrial viability level.
It has been described that Ab oligomers increase intra-
cellular calcium [28]. We showed that Ab in the presence
of AChE produces Ab oligomers faster than Ab aggre-
gates incubated without the enzyme, an effect that could
explain why the alterations triggered by Ab-AChE com-
plexes were stronger at Ca
2+ homeostasis level.
Previous studies from our laboratory indicated that
lithium protects hippocampal neurons against Ab pep-
tide and Ab-AChE complex neurotoxicity [22,38]. Addi-
tionally, we found that pre-incubation with Wnt-7a
ligand prevents the increase in cytosolic calcium
induced by Ab [39]. Hence, in order to study whether
Wnt signaling had any effect over the observed calcium
increase, we performed time-lapse experiments co-treat-
ing neurons with Ab-AChE complexes in the presence
of Wnt-7a or lithium. These experiments proved that
Wnt-7a and lithium prevent the cytoplasmic calcium
influx induced by these complexes. These results are
also consistent with the idea that lithium induces
NMDA receptor inactivation with a concomitant
decrease in the cytosolic calcium increase induced by
glutamate [40]. Moreover, lithium treatment reduced
the level of NR2B subunit phosphorylation at Tyr1472
which results in inactivation of NMDA receptors contri-
buting to neuroprotection against glutamate excitotoxi-
city [40]. Furthermore, it has been reported that lithium
robustly protected individual brain mitochondria loaded
with Rhodamine 123 (mitochondrial potential dye)
against Ca
2+-induced depolarization, an event that was
mediated by inhibition of mPTP activation by lithium
[41]. Taken together, this evidence and our studies
allow us to suggest a novel and interesting role of
lithium protection against mitochondrial dysfunction
triggered by calcium dyshomeostasis.
Excessive glutamate, an abundant neurotransmitter in
the brain, is toxic to neurons and can lead to intracellu-
lar calcium overload and neuron death. Overstimulation
of the glutamatergic system, also known as glutamate
excitotoxicity is observed in a number of neurodegen-
erative diseases including AD [42]. In fact, memantine,
an open-channels blocker of the NMDA receptor is use
to treat moderate and severe AD [43].
We have studied here, the role of the NMDA receptor
in neurotoxic effects induced by Ab-AChE complexes
using MK-801, a glutamate receptor antagonist, our stu-
dies indicates that the NMDA receptor antagonist, totally
prevents the cytoplasmic calcium influx induced by the
complex. Therefore, it may be possible that the decrease
observed in calcium cytosolic levels may be due in part
to inactivation of the NMDA receptors by lithium.
Further studies are necessary to clarify this issue.
Conclusions
We report here new findings about the Ab-AChE com-
plex mechanism, which includes a massive cytoplasmic
calcium influx and severe mitochondrial dysfunction in
rat hippocampal neurons. The pathologic entry of cal-
cium determines that mitochondria participate in the
buffering of cation excess, and this process leading to its
membrane depolarization and loss of viability. The
increased Ab-AChE complexes neurotoxicity observed
with regard to Ab aggregates could be explained by a
rapid loss of the mitochondrial membrane potential.
These events may be related to key neuropathological
mechanism of AD, and Ab-AChE complexes might
cause further damage through changes in calcium
homeostasis and mitochondrial function, as well as at
other neuronal levels.
Methods
Reagents
Synthetic Ab1-42 and Ab42-1 peptides corresponding to
the human Ab wild-type and reverse sequence, respec-
tively and both were obtained from Genemed Synthesis,
Inc. (San Francisco, CA). Chemicals, culture media and
sera were obtained from Sigma (St. Louis, MO), Roche
(Alameda, CA), Merck (Darmstadt, Germany), Gibco
BRL (Paisley, UK). Fluo-3 AM, Calcein-AM, Fura Red
AM, and Bapta AM from Molecular Probes (Eugene,
OR). Rhod-2AM, and TMRM
+ (Xanthylium,3,6-bis
(dimethylamino)-9-(2-(methoxycarbonyl)phenyl)-, per-
c h l o r a t e )w e r eak i n dg i f to fD r .L u i sF e l i p eB a r r o s
(CECS, Valdivia, Chile).
AChE Purification
Tetrameric G4 AChE form (sedimentation coefficient,
10.7 S) was purified from bovine caudate nucleus, using
acridine affinity chromatography as previously described
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staining intensity after sodium dodecyl sulfate-polyacry-
lamide gel electrophoresis were used to verify purity.
Formation of Amyloid Species
Ab aggregates were formed in a turbidity assay as pre-
viously described [45]. Briefly, For Abfa n dA b-AChEf,
the Ab peptide stock solution was prepared by dissol-
ving freeze-dried aliquots of Ab in dimethyl sulfoxide
(DMSO) at 15 mg/ml (3.5 mmol/L). An aliquot of this
stock solution equivalent to 15 μgo fA b peptide was
added to aqueous buffer (725 μl total volume; 100 μM
PSB, pH 7.4). For the aggregation assay in the presence
of AChE, an identical aliquot of the stock solution was
added to a buffer containing AChE (100 nM). The solu-
tions were stirred continuously (1,350 rpm) at room
temperature for 24 h and then left at 4°C for another 48
h, then an aliquot was taken and observed by electron
microscopy. Aggregation was measured by turbidity at
405 nm against a buffer blank. Amyloid aggregates
obtained were characterized by Thioflavin-T (Th-T)
binding [45].
Preparation of Ab oligomers
Aboligomers were formed using Ab peptide in the pre-
sence of AChE. Briefly, a 50 μMA b stock solution was
prepared in the presence of 50 nM AChE. The solution
was kept at 37°C for 1 h and then used immediately. An
aliquot of Abo and Ab-AChEo was separated by centri-
fugation at 14,000 rpm (15 min) for electron micro-
scopy. The supernatant was saved for non-denaturing
SDS-PAGE gels using SDS-free and b-mercaptoethanol-
free loading buffer and then regular western blot.
Electron microscopy
Fresh aliquots of samples were diluted 1:3 in water and
5 bl placed on Parlodion/carbon-coated 300-mesh cop-
per grids for 60s. Excess sample was removed and 5 μl
of 2% aqueous uranyl acetate was placed onto the grid
for 10s, followed by removal of excess staining solution
with filter paper and air-drying. Observations were car-
ried out using a Philips Tecnai 12 electron microscope
operated at 80 kV. Photographs were taken at original
magnifications of 49,000×. Copies from the negatives
were made with a further 3× magnification of given
areas and used for figure presentation.
Culture of rat hippocampal neurons
Hippocampi from Sprague-Dawley rats at embryonic
day 18 were dissected and primary rat hippocampal cul-
tures were prepared as described previously [39,45].
Hippocampal cells were seeded in polylysine-coated
wells and cultivated in Neurobasal medium supplemen-
ted with B27, on day 3 of culture; cells were treated
with 2 μM1 - b-D-arabinofuranosylcytosine (AraC) for
24 h to reduce most of the glial cells present in the cul-
ture. Seven days later, cultured hippocampal neurons
were used for various experiments. The average number
of neurons in each experiment corresponded approxi-
mately to 98% of total cells present in the cultures.
Cell survival assay
Cell viability was measured by the modified 3-[4,5-
dimethylthiazol-2yl]-2,5-diphenyltetrazolium bromide
(MTT) assay as described previously [45].
Immunofluorescence staining
Hippocampal neurons plated on polylysine-coated cov-
ers (25,000 cells/cover) were treated and then fixed with
4% paraformaldehyde/4% sucrose in PBS for 20 min,
permeabilized with 0.2% Triton-X100 for 5 min, blocked
with 0.2% gelatine and immunostained using an anti-
Map-1B, neurofilament protein, synapsin-1 or PSD-95
antibody (1:500). Coverslips were mounted and then
analyzed under a Zeiss confocal microscope.
Morphometric analysis
The number and length of neurites were quantified
using an Image-Pro plus software as described pre-
viously [38].
Caspase-3 Activity
Hippocampal neurons 15 DIV were treated with Ab-
AChEf, Aboa n dA bf for 1 h at 37°C, then the cells
were homogenized with RIPA buffer and then lysates
were centrifuged at 15,000 g for 20 min at 4°C, the
supernatant were collected to determinate Caspase
activity. Caspase-3, substrate chromogenic (Upstate Bio-
technology Inc., Lake Placid, NY, USA) was prepared in
12.5 mM buffer Hepes; 31.25 w/v Sucrose; 0,3125 w/v
CHAPS pH 7.4. The reaction was measured at 405 nm
in a microtiter plate reader.
Ab-AChE in plasmatic membrane
Hippocampal neurons 15 DIV were treated with Ab-
AChEo (1 or 5 μM) or AChE alone (1 or 5 nM) for 1 h
and membrane surface proteins were biotinylated with
sulfo-NHS-LC-biotin (Pierce) in a final concentration of
0.5 mg/mL for 45 min. After biotinylation step, the free
biotin was quenched by incubation with 50 mM NH4Cl
for 10 min. Cells were lysed in ice-cold SA buffer (150
m MN a C l ;2 0m MT r i sp H8 . 0 ;5m ME D T A ;1 %T r i -
ton-X-100; 0.2% BSA and protease inhibitors). Nuclear
and cellular debris was removed by centrifugation at
14,000 x g for 5 min at 4 °C and the biotinylated cell-
surface proteins were then adsorbed to streptavidin
agarose beads for 16 h at 4 °C. Beads were washed and
bound proteins were analyzed by SDS-PAGE followed
by immunoblotting against AChE. The values for bioti-
nylated cargo proteins were normalized to total cargo
proteins expressed in the cells.
Mitochondria membrane potential
Changes in mitochondrial membrane potential was
determined by specific mitochondrial probe TMRM
+
and detected in a confocal microscope [19,46]. Neurons
were grown on poly-L-lysine-coated glass coverslips and
cultured for 5 days. The cells were then loaded for 30
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+ in Krebs-Ringer-Hepes (136
mM NaCl; 20 mM Hepes; 4.7 mM KCl; 1.25 mM
MgSO4;1 . 2 5m MC a C l 2) (KRH)-glucose containing
0.02% pluronic acid, then washed, and allowed to equili-
brate for 30 min. Coverslips were then mounted in a
chamber on the stage of a confocal laser scanning
microscope (LSM Pascal Zeiss model 510, Carl Zeiss
Ltd.). The fluorescence changes determined by TMRM
fluorescence indicated them i t o c h o n d r i ap o t e n t i a l
changes. Images were acquired using a 543-nm He-Ne
laser to excite TMRM
+ and the signals were collected at
570 nm [18-20]. Signal from control neurons and neu-
rons treated with Ab-AChE complexes were compared
using identical settings for laser power, confocal thick-
ness and detector sensitivity. The images were analyzed
with Zeiss confocal software, the mean TMRM
+ fluores-
cence signal was measured per live cell. Estimation of
fluorescence intensity of TMRM
+ was presented like the
pseudoratio (ΔF/Fo) indicated by: ΔF/Fo =( F - F base)/
(Fbase-B), where F is the measured fluorescence intensity
of the indicator, Fbase is the fluorescence intensity before
the stimulation, and B is the background signal deter-
mined from the average of areas adjacent to the cells.
For mitochondrial membrane potential by MitoTracker
fluorescence, hippocampal neurons 15 DIV were treated
with Ab-AChEf, Aboa n dA bf for 1 h at 37°C. Then,
cells were stained with MitoTrackers-fx (Molecular
Probes, Eugene, OR). In all treatments, individual cover-
slips were rinsed twice in PBS and loaded with 10-500
nM MitoTracker for 15 min at 37°C. Dyes were diluted
in PBS from a 1 mM stock in anhydrous dimethyl sulf-
oxide. Coverslips were rinsed for 15 min in PBS at
room temperature. Loading parameters were tested and
optimized for assessing fluorescence intensity and locali-
zation in Confocal Zeis Microscope and the quantifica-
tion was made using Image J Program.
Cytoplasmic Calcium Imaging
Neurons grown on glass coverslip were loaded for 30
min (37°C) with the following fluorescent probes as
their acetoxymethyl (AM) ester forms: 5 μMF l u o - 3A M
and 10 μMR h o d - 2A Mi nK r e b s - R i n g e r - H e p e s( K R H ) -
glucose containing 0.02% pluronic acid. The fluores-
cence changes determined by Fluo-3 represent the cyto-
plasmic calcium [Ca
2+]cyt changes. Coverslips were
washed three times with PBS and left in KRH-glucose
for 10 min until cell fluorescence had reach plateau.
Fluorescence was imaged with a confocal laser scanning
microscope as described previously [19]. Images were
acquired using a 488-nm Argon laser to excite Fluo-3
and Fura-Red fluorescence. The signals were collected at
505-530 nm (Fluo-3). Background was measured in
parts of the field devoid of cells and found to be not sig-
nificantly different from the signal recorded in cells
depleted of dye with 100 μM digitonin. This value was
subtracted from cell measurements. The fluorescence
intensity variation was recorded from 15-20 neurons in
average per experiment. Estimation of fluorescence
intensity of Fluo-3 was presented like the pseudoratio
(ΔF/Fo), as indicated before [18-20].
Cell membrane integrity
Hippocampal neurons were loaded 30 min with Calcein-
AM (Molecular Probes, Leiden, Netherlands) as an indi-
cator of cell integrity [19].
Mitochondrial Calcium Measurements
Hippocampal neurons were grown on 35-mm dishes
and loaded with 5 ìM Rhod-2 AM in KRH-glucose buf-
fer containing 0.02% pluronic acid. The fluorescence
changes determined by Rhod-2 indicate calcium changes
in the mitochondria [19]. To estimate Rhod-2 fluores-
cence pattern in live mitochondria, we used Mito-
Tracker Green™ (MTG) to mark the mitochondria. Cells
were washed 3 times and left in KRH-glucose buffer for
10 min until cell fluorescence equilibrated. Fluorescence
was imaged with a confocal laser scanning microscope
(Leica TCS SP1) using a 40× water immersion lens.
Images were acquired using a 488-nm argon laser to
excite MTG fluorescence and a 563-nm He-Ne laser to
excite Rhod-2 fluorescence. The signals were collected
at 505-530 nm (MTG) and at 590 nm (Rhod-2). Fluores-
cence background signal was subtracted from cell fluor-
escence measurements in every experiment. The
fluorescence intensity variation was recorded from 5-10
cells on average per experiment. Estimation of fluores-
cence intensities were presented as the pseudoratio (ΔF/
Fo), which was calculated using the formula ΔF/Fo =( F
-F base)/(Fbase - B), where F is the measured fluorescence
intensity of the indicator, Fbase is the fluorescence inten-
sity before the stimulation, and B is the background sig-
nal determined from the average of areas adjacent to
the cells [21].
Statistical analysis
Results were expressed as mean ± standard error. Stu-
dent’s t test and the Mann-Whitney test were used for
analyzing data for fluorescence measurements and
image analysis. P < 0.05 was regarded as statistically
significant.
Additional file 1: Characterization of the aggregates used for the
experiments by electron microscopy. Negative stain and electron
microscopy photographs for 5 μMo f( A )A b-AChEf and (B) Ab-AChEo
preparations used in the experiments.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1750-1326-5-4-
S1.PDF]
Additional file 2: Effect of Ab and Ab-AChE aggregates on synaptic
proteins. Immunofluorescence assay for PSD-95 of hippocampal neurons
treated with (A) control or 1 μM of (B) Abo, (C) Abf, (D) Ab-AChEo, (E)
Ab-AChEf. Also a magnification of neurites in each treatment is showing.
The imunofluorescence correspond to synapsin-1 (red) and PSD-95
(green).
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